Abstract
One of the most characteristic features of the chromoblastomycosis is its unresponsiveness to treatment. In order to analyzed whether during therapy could be observed a change of cellular immune response pattern, we evaluated the production of IL-10, TNF-α and IFN-γ, as well as proliferation of peripheral blood mononuclear cell (PBMC) from patients in different periods of chemotherapy treatment. Our results showed that after 6 months of treatment cells from patients proliferated to fungal antigens and produced a significant level of IFN-γ. However, after 1 year of treatment a low proliferation of T cells and production of IFN-γ accompanied by an increase of IL-10 were observed when compared with 6 months of treatment.
Similar content being viewed by others
References
AT Londero CD. Ramos (1976) ArticleTitleChromomycosis. A clinical and mycological study of 35 cases observed in the hinterland of Rio Grande do Sul Brazil Am J Trop Med Hyg. 25 132–135 Occurrence Handle1:STN:280:DyaE287lvVCktQ%3D%3D
MR McGinnis L Ajello MS. Schell (1985) ArticleTitleMycotic diseases. A proposed nomenclature Int J Dermatol 24 9–15 Occurrence Handle3888877 Occurrence Handle1:STN:280:DyaL2M3gs1Giug%3D%3D
Rippon JW. Chromoblastomycosis. In: Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomycetes, WB Sunders, Philadelphia, 1988: 276–298.
AT Londero CD. Ramos (1989) ArticleTitleCromoblastomicose no interior do estado do Rio Grande do Sul Bras Dermatol 64 155–158
Al-Doory Y. Chromomycosis. In: Occupational Mycosis, Lea & Febiger, Philadelphia, 1983: 95–99.
MR. McGinnis (1983) ArticleTitleChromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology J Am Acad Dermatol 8 1–16 Occurrence Handle6826791 Occurrence Handle1:STN:280:DyaL3s7js1Cgtw%3D%3D Occurrence Handle10.1016/S0190-9622(83)70001-0
FF Queiroz Telles K Purim JN. Fillus (1992) ArticleTitleItraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi Int J Dermatol 31 805–812 Occurrence Handle1330949 Occurrence Handle1:STN:280:DyaK3s%2FltlSquw%3D%3D
A Restrepo A González I. Gomez (1988) ArticleTitleTreatment of chromoblastomycosis with itraconazole Ann N Y Acad Sci 544 504–516 Occurrence Handle2850755 Occurrence Handle1:STN:280:DyaL1M7gsVaitw%3D%3D
JR. Graybill (1992) ArticleTitleFuture directions of antifungal chemotherapy Clin Infect Dis 14 IssueIDSuppl 1 S170–S181 Occurrence Handle1562690
LGM. Castro (1992) ArticleTitleChromomycosis: a therapeutic challenge Clin Infect Dis 15 553–557 Occurrence Handle1325840 Occurrence Handle1:STN:280:DyaK38zptlSjtw%3D%3D
D. Borelli (1987) ArticleTitleA clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis Rev Infect Dis 9 57–63
P Esterre M Jahevitra A. Andriantsimahavandy (2000) ArticleTitleHumoral immune response in chromoblastomycosis during and after therapy Clin Diag Lab Immunol 7 497–500 Occurrence Handle1:CAS:528:DC%2BD3cXjslWisL8%3D Occurrence Handle10.1128/CDLI.7.3.497-500.2000
N. Kurita (1979) ArticleTitleCell mediated immune responses in mice infected with Fonsecaea pedrosoi Mycopathologia 68 9–12 Occurrence Handle386129 Occurrence Handle1:STN:280:DyaL3c%2Fjt1ynsg%3D%3D Occurrence Handle10.1007/BF00490385
VMF Gimenes MG Sousa KS Ferreira SG Marques AG Gonçalves DVCL Santos CMP Silva Azevedo Particlede SR. Almeida (2005) ArticleTitleCytokine and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis Microbes Infect 7 708–713 Occurrence Handle1:CAS:528:DC%2BD2MXkt1Gnsbg%3D
MM. Bradford (1976) ArticleTitleA rapid and sensitive method for the quantitation of microgram quantities of protein resing the principle of protein-dye binding Anal Biochem 72 248–259 Occurrence Handle942051 Occurrence Handle1:CAS:528:DyaE28XksVehtrY%3D Occurrence Handle10.1016/0003-2697(76)90527-3
KA Marr T Patterson D. Denning (2002) ArticleTitleAspergillosis. Pathogenesis, clinical manifestations, and therapy Infect Dis Clin North Am 16 875–894 Occurrence Handle12512185 Occurrence Handle10.1016/S0891-5520(02)00035-1
PL Fidel JD. Sobel (1994) ArticleTitleThe role of cell-mediated immunity in candidiasis Trends Microbiol 2 202–206 Occurrence Handle8087452 Occurrence Handle10.1016/0966-842X(94)90112-I
P Puccetti L Romani F. Bistoni (1995) ArticleTitleA th1–th2-like switch in candidiasis: new perspectives for therapy Trends Microbiol 3 237–240 Occurrence Handle7648032 Occurrence Handle1:STN:280:DyaK2Mzns1SmtA%3D%3D Occurrence Handle10.1016/S0966-842X(00)88931-3
K Clemons DA. Stevens (2001) ArticleTitleOverview of host defense mechanisms in systemic mycosis and the basis for immunotherapy Semin. Respir. Infect. 16 60–66 Occurrence Handle11309713 Occurrence Handle1:STN:280:DC%2BD3MvkslOqtQ%3D%3D Occurrence Handle10.1053/srin.2001.22729
MG Netea PM Schneeberger E. Vries Particlede (2002) ArticleTitleTh1/Th2 cytokines imbalance in a family with hyper-IgE syndrome Neth J Med 60 349–353 Occurrence Handle12572706 Occurrence Handle1:CAS:528:DC%2BD3sXms1yqur8%3D
SJ Oliveira RL Mamoni CC Musatti MH. Bottla (2002) ArticleTitleCytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls Microbes Infect 4 139–144 Occurrence Handle11880044 Occurrence Handle1:CAS:528:DC%2BD38XhslWgur4%3D Occurrence Handle10.1016/S1286-4579(01)01521-0
A Bozzi BS Reis FL Prado A. Goes (2004) ArticleTitleModularion of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment Scand J Immunol 60 500–505 Occurrence Handle15541043 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOhu73K Occurrence Handle10.1111/j.0300-9475.2004.01501.x
E Rolides T Sein R Schaufele SJ Chanock TJ. Walsh (1998) ArticleTitleIncreased serum concentration of IL-10 inpatients with hepatosplenic candidiasis J Infect Dis 178 589–592
MT Peraçoli CS Kurokaw SA. Calvi (2003) ArticleTitleProduction of pro- and anti- inflammatory cytokines by monocytes from patients with paracoccidioidomycosis Microbes Infect 5 413–418 Occurrence Handle12737997 Occurrence Handle10.1016/S1286-4579(03)00040-6 Occurrence Handle1:CAS:528:DC%2BD3sXjsVGksLo%3D
E Roilides T Sein M Roden RL Schaufele TJ. Walsh (2001) ArticleTitleElevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis J Infect Dis 183 518–520 Occurrence Handle11133388 Occurrence Handle1:STN:280:DC%2BD3M7isFOkug%3D%3D Occurrence Handle10.1086/318077
L Romani SH. Kaufmann (1998) ArticleTitleImmunity to fungi Res Immunol 149 281–493 Occurrence Handle10.1016/S0923-2494(98)80752-9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gimenes, V.M.F., Criado, P.R., Martins, J.E.C. et al. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy. Mycopathologia 162, 97–101 (2006). https://doi.org/10.1007/s11046-006-0041-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11046-006-0041-x